3.85%C 7.22 11.94%GE 17.61 13.61%
The Global Business News Leader | Tuesday, 2 Dec 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- INVESTING
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
PFIZER INC
PFE (NYSE)
$ 16.02 
Change: +0.74 +4.62% | Volume: 43,476,431
Change: +0.74 +4.62% | Volume: 43,476,431
Sponsored by 
PFIZER INC - Fundamental Profile
Company Information
| Ticker Symbol: | PFE |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 235 East 42nd Street New York 10017-5755 212 573-2323 |
| CEO/President: | Henry A. McKinnell |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer has three business segments: health care, animal health and consumer health care. Its products are available in numerous countries. (Company Press Release) |
Share Information
| Shares Outstanding: | 6,740,990 (000) | Market Value: | 108,327,776 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 83.80% | Number of Inst.Shareholders: | 0.30% |
| Last Quarter Sales: | 11973.00 ($Mil.) | Last Quarter Net Income: | 2278.00 ($Mil.) |
| Last Quarter EPS: | 0.62 | P/E Ratio: | 7 |
| Most Recent Earnings: | 0.62 on 10/21/08 | Earnings Per Share: | 1.58 |
| Most Recent Split: | 3-1 on 07/01/99 | Annual Dividend Rate: | 1.28 |
| Most Recent Dividend: | 0.320 on 11/05/08 | Annual Dividend Yield: | 7.97% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
PFE
Companies
IBT
- Analyst expects aggressive M&A in big pharma
- Pfizer opening unit to focus on stem cells
- Pfizer puts closed Terre Haute plant up for sale
- Targanta shares plummet on negative FDA panel vote
- Medivation shares fall on new Dimebon timeline
- Sector Snap: Obesity drug developers
- Companies push Congress for pension relief
- Oil tumbles below $50 as recession called
- Ahead of the Bell: Construction Spending
- Ahead of the Bell: St. Jude Medical
- '12 Days of Christmas' items would cost $86,609
- Manufacturing index drops to 26-year low
- Ford weighs selling Volvo amid industry downturn
- Ford says CEO will work for $1 to get gov't loans
- U.S. Stocks Tumble into the Red Zone in Afternoon Trade
- U.S. Stocks Gain on Potential Auto Bailout
- U.S. Stocks Dive Ahead of Economic Reports; Ford, GM Gain
- USD/JPY - 93.68 Daily Market Outlook - Dec 1
- JPY Rallies of Safe-Haven Flows
- Vales shares may decrease 1 Pct on Bovespas index by 2009
- Toyota Group to start importing rare-earth metals from India, Vietnam
Top Competitors
| PFIZER INC |  |
-34.60 | 15.28 |
| JOHNSON AND JOH | |
-20.70 | 55.33 |
| BRISTOL MYERS S | |
-27.60 | 19.36 |
| SCHERING PLOUGH | |
-42.70 | 15.55 |
| MERCK CO INC | |
-58.70 | 24.85 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives